Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zeng, Yaoming
NCT06753890: Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)	Not yet recruiting	3	520	RoW	Changkang granules, Changkang Granules placebo	Tasly Pharmaceutical Group Co., Ltd	Diarrhea-predominant Irritable Boewl Syndrome	11/26	12/26
NCT06696261: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome	Not yet recruiting	3	342	RoW	Lianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi Granules	Tasly Pharmaceutical Group Co., Ltd	Postprandial Distress Syndrome	06/26	08/26